Clover Biopharmaceuticals, Ltd announced that it will receive $320,713 in funding on April 2, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 HKD | -1.45% | -6.85% | -45.16% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.16% | 57.3M | |
+16.13% | 122B | |
+19.65% | 113B | |
+17.61% | 26.49B | |
-23.84% | 19.4B | |
-19.10% | 16.24B | |
-19.28% | 15.4B | |
-45.95% | 15.15B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals, Ltd. announced that it expects to receive $0.320713 million in funding